New drug combo trial offers hope for Tough-to-Treat cancers
Disease control
Recruiting now
This study is testing a new drug called FL115 when given together with an existing immunotherapy drug (Sintilimab) for people with advanced solid tumors. The main goals are to find a safe dose and see if the combination shows early signs of helping to control the cancer. About 13…
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Forlong Biotechnology Co., Ltd • Aim: Disease control
Last updated Mar 16, 2026 15:25 UTC